🟢 Pacific Biosciences is trading 6.35% up amid Verily Health collaboration on AI-ready genomic datasets

Pacific Biosciences is trading 6.35% higher at $1.84 on October 19, 2026, amid its announced multi-year collaboration with Verily Health to create AI-ready genomic and clinical datasets.

• The collaboration combines PacBio HiFi sequencing with Verily’s data and AI platform; no financial terms were provided.
• Technology and biotech sentiment also improved during the session, providing supportive context. The report does not explicitly link the share-price move to the collaboration.